The Legal and Moral Implications of Giving Indemnity to Companies Manufacturing the Covid-19 Vaccine

  • Anoushka Singha and Yashasvi Suroliya
  • Show Author Details
  • Anoushka Singha

    Student at Government Law College, Mumbai, India

  • Yashasvi Suroliya

    Student at Government Law College, Mumbai, India

  • img Save PDF


The sudden and deadly onset of the Coronavirus-19 (COVID-19) pandemic has led to a worldwide demand for vaccinations, as governments and organizations attempt to safeguard public health through mass immunization. However, the unique nature of COVID-19 combined with previous lessons from mass inoculation programmes has made vaccine manufacturers more cautious. Indeed, indemnification from Adverse Effects post Inoculation (AEIs) caused by vaccinations, which in previous health crises was not granted to vaccine manufacturing companies, is increasingly sought and guaranteed to them by governments across the world. This article analyses the alternative means to settle victims’ AEI claims that have been evolved by governments and organizations, as well as the legal and moral issues arising from the same.


Research Paper


International Journal of Legal Science and Innovation, Volume 4, Issue 1, Page 549 - 555


Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution -NonCommercial 4.0 International (CC BY-NC 4.0) (, which permits remixing, adapting, and building upon the work for non-commercial use, provided the original work is properly cited.


Copyright © IJLSI 2021